Determination of O‐(chloroacetylcarbamoyl)fumagillol (TNP‐470; AGM‐1470) and two metabolites in plasma by high‐performance liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization
- 1 December 1995
- journal article
- Published by Wiley in Journal of Mass Spectrometry
- Vol. 30 (12) , 1707-1715
- https://doi.org/10.1002/jms.1190301211
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Assay of the antiangiogenic compound TNP-470, and one of its metabolites, AGM-1883, by reversed-phase high-performance liquid chromatography in plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1994
- Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470)British Journal of Cancer, 1994
- The influence of angiogenesis inhibitor AGM‐1470 on immune system status and tumor growth in vitroInternational Journal of Cancer, 1993
- The combination of antiagniogenic agents to inhibit primary tumor growth and metastasisJournal of Pediatric Surgery, 1993
- Analysis of experimental antiangiogenic therapyJournal of Pediatric Surgery, 1993
- Inhibition of angiogenesis and growth of human nerve-sheath tumors by AGM-1470Journal of Neurosurgery, 1993
- Angiogenesis inhibition suppresses collagen arthritis.The Journal of Experimental Medicine, 1992
- Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growthNature, 1990